Walnut Creek, California (CA) Commercial Physical and Biological Research Companies
Featured companies
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Affitech A/S
Ole Maaløes Vej 3, DK 2200 Copenhagen N, Denmark
Walnut Creek CA 945952347
(925) 935-9803
Affitech AS is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic antibody company based in Copenhagen, Denmark with R&D facilities in Oslo,
Northrop Grumman Space & Mission Systems Corp
1350 Carlback Avenue # 120
Walnut Creek CA 94596
(925) 256-1277
Whereorg has 82 results under Commercial Physical and Biological Research Companies in Walnut Creek, CA.
Narrow down the browsing criteria below to see more companies.
Select a category for location Contra Costa, California
Other locations for category Commercial Physical and Biological Research
Quick navigation
Subcategory
- Agricultural Laboratories1
- Biological Research2
- Biotechnology Products and Services1
- Commercial Biotechnical Research2
- Commercial Medical Research1
- Commercial Research Laboratory1
- Electronic Research and Development1
- Energy Research22
- Engineering Laboratory, Except Testing1
- Environmental and Ecological Services24
- Ergonomics1
- Food Analysis1
- Laboratories1
- Research and Development Laboratories22
- Solar Energy Research and Development1
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020